Your gift is 100% tax deductible
What Causes Kaposi Sarcoma?
Kaposi sarcoma (KS) is caused by infection with a virus called the Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8). KSHV is in the same family as Epstein-Barr virus (EBV), the virus that causes infectious mononucleosis (mono) and is linked to several types of cancer.
In KS, the cells that line blood and lymphatic vessels (called endothelial cells) are infected with KSHV. The virus brings genes into the cells that can cause the cells to divide too much and to live longer than they should. These same genes may cause the endothelial cells to form new blood vessels and may also increase the production of certain chemicals that cause inflammation. These types of changes may eventually turn them into cancer cells.
KSHV infection is much more common than KS. Most people infected with this virus do not get KS and many will never show any symptoms. Infection with KSHV is needed to cause KS, but in most cases infection with KSHV alone does not lead to KS. Most people who develop KS have the KSHV and also have a weakened immune system, due to HIV infection, organ transplant, being older, or some other factor.
The number of people infected with KSHV varies in different places around the world. In the United States, studies have found that less than 10% of people are infected with KSHV. The infection is more common in people infected with HIV than in the general population in the United States. KSHV infection is also more common in men who have sex with men than in men who only have sex with women.
In some areas of Africa, up to 80% of the population shows signs of KSHV infection. In these areas the virus seems to spread from mother to child. KSHV is also found in saliva, semen, and vaginal fluid, which may be some ways it is passed to others.
For more on infections and their role in cancer, see Infections That Can Lead to Cancer.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Brown EE, Whitby D, Vitale F, et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 2006;107:2282−2290.
Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis. 2007;196:199−207.
Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: Epidemiology and risk factors. Cancer. 2000;88:500−517.
Minhas V, Wood C. Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus. Zheng Z-M, ed. Viruses. 2014;6(11):4178-4194.
Yarchoan R, Uldrick TS, Polizzotto MN, Little RF. Ch. 117 - HIV-associated malignancies. In: DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2015.
Last Revised: April 19, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
